+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rheumatoid Arthritis"

From
Prescriber Opinions on Biosimilars in Immunology - Product Thumbnail Image

Prescriber Opinions on Biosimilars in Immunology

  • Report
  • March 2021
  • 45 Pages
  • Global
From
Biosimilars in Immunology - Product Thumbnail Image

Biosimilars in Immunology

  • Report
  • February 2020
  • 137 Pages
  • Global
From
Disease Analysis: Rheumatoid Arthritis - Product Thumbnail Image

Disease Analysis: Rheumatoid Arthritis

  • Report
  • May 2021
  • 94 Pages
  • Global
Competitor Landscape: Rheumatoid Arthritis - Product Thumbnail Image

Competitor Landscape: Rheumatoid Arthritis

  • Report
  • October 2018
  • 71 Pages
  • Global
From
Digital Landscape: Rheumatoid Arthritis - Product Thumbnail Image

Digital Landscape: Rheumatoid Arthritis

  • Report
  • September 2018
  • 162 Pages
  • Global
From
KOL Perspectives: Upadacitinib for Rheumatoid Arthritis - Product Thumbnail Image

KOL Perspectives: Upadacitinib for Rheumatoid Arthritis

  • Report
  • August 2018
  • 24 Pages
  • Global
From
Digital Marketing Trends in Rheumatoid Arthritis - Product Thumbnail Image

Digital Marketing Trends in Rheumatoid Arthritis

  • Report
  • March 2023
  • 36 Pages
  • Global
From
Digital Health in Immunology - Thematic Research - Product Thumbnail Image

Digital Health in Immunology - Thematic Research

  • Report
  • December 2021
  • 57 Pages
  • Global
From
From
From
ABC of Rheumatology. Edition No. 5. ABC Series - Product Thumbnail Image

ABC of Rheumatology. Edition No. 5. ABC Series

  • Book
  • April 2018
  • 224 Pages
Vaccines and Autoimmunity. Edition No. 1 - Product Thumbnail Image

Vaccines and Autoimmunity. Edition No. 1

  • Book
  • June 2015
  • 392 Pages
Rheumatology Board Review. Edition No. 1 - Product Thumbnail Image

Rheumatology Board Review. Edition No. 1

  • Book
  • July 2014
  • 224 Pages
Loading Indicator

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes. The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments. Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more